| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers E > Headlines for Elevance Health, Inc. > News item |
S&P rates Elevance notes A
S&P said it rated Elevance Health Inc.'s senior unsecured notes, which will be issued in three, 10-, and 30-year tranches A.
The rating is the same as the issuer rating and the rating on the $1.8 billion of notes the company sold in October.
Elevance plans to use the proceeds for general corporate purposes, including the refinancing of $500 million of senior unsecured notes due March 2023 and the acquisition of BioPlus, expected to close in the first half of 2023.
The outlook is stable.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.